105 related articles for article (PubMed ID: 28204822)
1. Melittin inhibits osteoclast formation through the downregulation of the RANKL-RANK signaling pathway and the inhibition of interleukin-1β in murine macrophages.
Choe JY; Kim SK
Int J Mol Med; 2017 Mar; 39(3):539-548. PubMed ID: 28204822
[TBL] [Abstract][Full Text] [Related]
2. Ethanol extract of Cyathulae Radix inhibits osteoclast differentiation and bone loss.
Shi L; Ren L; Li J; Liu X; Lu J; Jia L; Xie B; Tang S; Liu W; Zhang J
Chin J Nat Med; 2024 Mar; 22(3):212-223. PubMed ID: 38553189
[TBL] [Abstract][Full Text] [Related]
3. Palmitoleic Acid Inhibits RANKL-Induced Osteoclastogenesis and Bone Resorption by Suppressing NF-κB and MAPK Signalling Pathways.
van Heerden B; Kasonga A; Kruger MC; Coetzee M
Nutrients; 2017 Apr; 9(5):. PubMed ID: 28452958
[TBL] [Abstract][Full Text] [Related]
4. Neobavaisoflavone inhibits osteoclastogenesis through blocking RANKL signalling-mediated TRAF6 and c-Src recruitment and NF-κB, MAPK and Akt pathways.
Chen H; Fang C; Zhi X; Song S; Gu Y; Chen X; Cui J; Hu Y; Weng W; Zhou Q; Wang Y; Wang Y; Jiang H; Li X; Cao L; Chen X; Su J
J Cell Mol Med; 2020 Aug; 24(16):9067-9084. PubMed ID: 32604472
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticulate bioceramic putty suppresses osteoclastogenesis and inflammatory bone loss in mice via inhibition of TRAF6-mediated signalling pathways: A laboratory investigation.
Wang Z; Zhang J; Sun X; Yu J; Liu B; Peng B; Wang L; Yang J; Zhu L
Int Endod J; 2024 Jun; 57(6):682-699. PubMed ID: 38403990
[TBL] [Abstract][Full Text] [Related]
6.
Rattajak P; Aroonkesorn A; Smythe C; Wititsuwannakul R; Pitakpornpreecha T
Molecules; 2024 May; 29(9):. PubMed ID: 38731604
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone resorption.
Wang L; Shi X; Zhao R; Halloran BP; Clark DJ; Jacobs CR; Kingery WS
Bone; 2010 May; 46(5):1369-79. PubMed ID: 19962460
[TBL] [Abstract][Full Text] [Related]
8. Trimethylamine-N-oxide promotes osteoclast differentiation and oxidative stress by activating NF-κB pathway.
Zhao Y; Wang C; Qiu F; Liu J; Xie Y; Lin Z; He J; Chen J
Aging (Albany NY); 2024 May; 16(10):9251-9263. PubMed ID: 38809508
[TBL] [Abstract][Full Text] [Related]
9. Interactomics profiling of the negative regulatory function of carbon monoxide on RANKL-treated RAW 264.7 cells during osteoclastogenesis.
Tseng FJ; Chia WT; Shyu JF; Gou GH; Sytwu HK; Hsia CW; Tseng MJ; Pan RY
BMC Syst Biol; 2014 May; 8():57. PubMed ID: 24886323
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of sodium pentosan polysulfate on formation and function of osteoclasts derived from canine bone marrow.
Wijekoon HMS; Bwalya EC; Fang J; Kim S; Hosoya K; Okumura M
BMC Vet Res; 2018 May; 14(1):152. PubMed ID: 29720166
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin inhibits osteoclast differentiation by scavenging reactive oxygen species.
Moon HJ; Kim SE; Yun YP; Hwang YS; Bang JB; Park JH; Kwon IK
Exp Mol Med; 2011 Nov; 43(11):605-12. PubMed ID: 21832867
[TBL] [Abstract][Full Text] [Related]
12. TRAF family member-associated NF-κB activator (TANK) induced by RANKL negatively regulates osteoclasts survival and function.
Wu M; Wang Y; Deng L; Chen W; Li YP
Int J Biol Sci; 2012; 8(10):1398-407. PubMed ID: 23139637
[TBL] [Abstract][Full Text] [Related]
13. Genetic disruption of Ano5 leads to impaired osteoclastogenesis for gnathodiaphyseal dysplasia.
Liu X; Wang X; Ma X; Li H; Miao C; Tian Z; Hu Y
Oral Dis; 2024 Apr; 30(3):1403-1415. PubMed ID: 36989132
[TBL] [Abstract][Full Text] [Related]
14. Autophagy-linked FYVE containing protein WDFY3 interacts with TRAF6 and modulates RANKL-induced osteoclastogenesis.
Wu DJ; Gu R; Sarin R; Zavodovskaya R; Chen CP; Christiansen BA; Zarbalis KS; Adamopoulos IE
J Autoimmun; 2016 Sep; 73():73-84. PubMed ID: 27330028
[TBL] [Abstract][Full Text] [Related]
15. Resolvin E1 Inhibits Osteoclastogenesis and Bone Resorption by Suppressing IL-17-induced RANKL Expression in Osteoblasts and RANKL-induced Osteoclast Differentiation.
Funaki Y; Hasegawa Y; Okazaki R; Yamasaki A; Sueda Y; Yamamoto A; Yanai M; Fukushima T; Harada T; Makino H; Shimizu E
Yonago Acta Med; 2018 Mar; 61(1):8-18. PubMed ID: 29599617
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral small hairpin RNA knockdown of macrophage inflammatory protein-1γ ameliorates experimentally induced osteoarthritis in mice.
Shen PC; Lu CS; Shiau AL; Lee CH; Jou IM; Hsieh JL
Hum Gene Ther; 2013 Oct; 24(10):871-82. PubMed ID: 24016310
[TBL] [Abstract][Full Text] [Related]
17. D-alanine suppressed osteoclastogenesis derived from bone marrow macrophages and downregulated ERK/p38 signalling pathways.
Chang X; Deng J; Zhou F; Geng Z; Li X; Wang S
Arch Oral Biol; 2024 May; 161():105912. PubMed ID: 38382164
[TBL] [Abstract][Full Text] [Related]
18. Orcinol gentiobioside inhibits RANKL-induced osteoclastogenesis by promoting apoptosis and suppressing autophagy via the JNK1 signaling.
Lian C; Gong W; Zhao X; Sun P; Hu S; Zhou G; Zhang Q; Qin L
J Ethnopharmacol; 2024 Jun; 328():118060. PubMed ID: 38521429
[TBL] [Abstract][Full Text] [Related]
19. Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures.
Fowler TW; Kamalakar A; Akel NS; Kurten RC; Suva LJ; Gaddy D
J Cell Sci; 2015 Feb; 128(4):683-94. PubMed ID: 25609708
[TBL] [Abstract][Full Text] [Related]
20. The novel cytotoxic polybisphosphonate osteodex decreases bone resorption by enhancing cell death of mature osteoclasts without affecting osteoclastogenesis of RANKL-stimulated mouse bone marrow macrophages.
Henning P; Westerlund A; Movérare-Skrtic S; Lindholm C; Márquez-Méndez M; Nilsson S; Holmberg AR; Lerner UH
Invest New Drugs; 2024 Apr; 42(2):207-220. PubMed ID: 38427117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
